» Articles » PMID: 19082784

Role of Advanced MR Imaging Modalities in Diagnosing Cerebral Gliomas

Overview
Journal Radiol Med
Specialty Radiology
Date 2008 Dec 17
PMID 19082784
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The objective of this study was to evaluate the potential role of newly developed, advanced magnetic resonance (MR) imaging techniques (spectroscopy, diffusion and perfusion imaging) in diagnosing brain gliomas, with special reference to histological typing and grading, treatment planning and posttreatment follow-up. Conventional MR imaging enables the detection and localisation of neoplastic lesions, as well as providing, in typical cases, some indication about their nature. However, it has limited sensitivity and specificity in evaluating histological type and grade, delineating margins and differentiating oedema, tumour and treatment side-effects. These limitations can be overcome by supplementing the morphological data obtained with conventional MR imaging with the metabolic, structural and perfusional information provided by new MR techniques that are increasingly becoming an integral part of routine MR studies. Incorporation of such new MR techniques can lead to more comprehensive and precise diagnoses that can better assist surgeons in determining prognosis and planning treatment strategies. In addition, the recent development of new, more effective, treatments for cerebral glioma strongly relies on morphofunctional MR imaging with its ability to provide a biological interpretation of these characteristically heterogeneous tumours.

Citing Articles

Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.

Anselmi M, Catalucci A, Felli V, Vellucci V, Di Sibio A, Gravina G Neuroradiol J. 2017; 30(3):240-252.

PMID: 28627984 PMC: 5480793. DOI: 10.1177/1971400916688354.


Diagnosis and New Treatment Modalities for Glioblastoma: Do They Improve Patient Survival?.

Alcedo-Guardia R, Labat E, Blas-Boria D, Vivas-Mejia P Curr Mol Med. 2015; .

PMID: 26585986 PMC: 10041888.


Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.

Cuccarini V, Erbetta A, Farinotti M, Cuppini L, Ghielmetti F, Pollo B J Neurooncol. 2015; 126(2):279-88.

PMID: 26468137 DOI: 10.1007/s11060-015-1960-5.


Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.

di Costanzo A, Scarabino T, Trojsi F, Popolizio T, Bonavita S, de Cristofaro M Radiol Med. 2014; 119(8):616-24.

PMID: 24408041 DOI: 10.1007/s11547-013-0371-y.


Spectroscopic evaluation of glioma grading at 3T: the combined role of short and long TE.

Kousi E, Tsougos I, Tsolaki E, Fountas K, Theodorou K, Fezoulidis I ScientificWorldJournal. 2012; 2012:546171.

PMID: 22919334 PMC: 3417198. DOI: 10.1100/2012/546171.


References
1.
Howe F, Opstad K . 1H MR spectroscopy of brain tumours and masses. NMR Biomed. 2003; 16(3):123-31. DOI: 10.1002/nbm.822. View

2.
Lu S, Ahn D, Johnson G, Cha S . Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol. 2003; 24(5):937-41. PMC: 7975803. View

3.
Rampling R, James A, Papanastassiou V . The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy. J Neurol Neurosurg Psychiatry. 2004; 75 Suppl 2:ii24-30. PMC: 1765659. DOI: 10.1136/jnnp.2004.040535. View

4.
Zeng Q, Li C, Zhang K, Liu H, Kang X, Zhen J . Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol. 2007; 84(1):63-9. DOI: 10.1007/s11060-007-9341-3. View

5.
Lam W, Poon W, Metreweli C . Diffusion MR imaging in glioma: does it have any role in the pre-operation determination of grading of glioma?. Clin Radiol. 2002; 57(3):219-25. DOI: 10.1053/crad.2001.0741. View